St. Jude revisits RESPECT trial, touts signs of benefits of Amplatzer device

February 8, 2013 by MassDevice staff

St. Jude Medical touts new findings from its failed RESPECT trial, reporting that the Amplatzer PFO closure device demonstrated benefits over drug therapy alone.

St. Jude Medical logo

Medical device giant St. Jude Medical (NYSE:STJ) resurrected data from its failed RESPECT study, touting additional analyses and benefits of its Amplatzer patent foramen ovale closure device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp